HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT
About HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT
HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT belongs to the class of medicines called ‘immunizing agents’. It is given to individuals aged nine to twenty-six years to prevent various diseases caused by Human Papillomavirus (HPV). Human papillomavirus (HPV) can cause genital warts, cancer of the cervix, anal cancer, and various cancers of the vulva or vagina.
HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT is a quadrivalent vaccine or immunizing agent which is made from a live and weakened or attenuated virus (mixture of virus-like particles derived from the L1 capsid proteins of HPV types 6, 11, 16 and 18). It helps develop immunity by stimulating the immune system to produce relevant antibodies. It is essential to take the vaccine doses as per the doctor’s advice to develop protection against the diseases.
HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT will be administered by a healthcare professional. In a few cases, HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT may cause side-effects such as fever, nausea, headache, redness, pain, and swelling at the injection site. These side-effects are temporary and resolve without any treatment. However, inform your doctor immediately if any of these side effects persist or get worse.
Before taking HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT, please notify your doctor if you are allergic to any medications. Inform your doctor if you have any allergies, a weakened immune system resulting from long-term diseases such as genetic disease, HIV, or cancer, a serious infection or illness with fever, a bleeding disorder, or immunological diseases before taking HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT. Let your doctor know if you are pregnant, think you may be pregnant or plan to have a baby or breastfeed. Keep your doctor informed about your health condition and all the medicines you take before taking HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT to rule out any side effects.
Uses of HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT
Medicinal Benefits
HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT is used to prevent Human papillomavirus (HPV)-associated cancers. It helps develop immunity by stimulating the immune system to produce antibodies against the Human papillomavirus that causes genital warts, cancer of the cervix, anal cancer, and various cancers of the vulva or vagina.
Directions for Use
Storage
Side Effects of HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT
- Injection site redness
- Injection site pain
- Injection site swelling
- Fever
- Nausea
- Headache
Patients Concern
Disease/Condition Glossary
Cancer: Cancer is a disease that is caused by the uncontrolled division of abnormal cells in a specific part of the body.
Genital warts: It is a common sexually transmitted infection (HPV). Symptoms include the development of small growths/bumps on the genital areas.
Cervical cancer: Cervical cancer, also known as cervix cancer, is a type of cancer that develops in the cells of the cervix. The sexually transmitted human papillomavirus is responsible for the majority of cervical cancer cases (HPV).
Anal cancer: Anal cancer is defined as abnormal cell growth in or around the anus or anal canal. The majority of anal cancers are caused by human papillomavirus (HPV) infection.
FAQs
HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT helps develop immunity by stimulating the immune system to produce relevant antibodies against the Human papillomavirus (HPV).
HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT may result in side effects such as injection site redness, pain, swelling, fever, nausea, and headache. These side effects usually go away on their own. However, if any of these side effects persist or worsen, contact your doctor right away.
The HPV quadrivalent vaccine is administered by the healthcare professional in three doses. You can get your first shot whenever you want as long as you're between the ages of 9 and 26. Then you'll need to get a second dose two months after your first shot and a third dose six months later.
There are no adequate and well-controlled studies on pregnant and nursing women. Inform your doctor before taking HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT. If you are pregnant or breastfeeding, think you may be pregnant or plan to have a baby. Your doctor will prescribe only if the benefits outweigh the risks.
HUMAN PAPILLOMAVIRUS QUADRIVALENT VACCINE RECOMBINANT should not be used in individuals with a weak immune system due to diseases (cancer or HIV) or medicines (immune suppressants), blood disorders, immunological diseases, and severe illness with fever.
